美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
40503 A II 2024/09/19 FUJIAN GENOHOPE BIOTECH LTD TIRZEPATIDE
40532 A II 2024/09/19 WUXI XDC CO LTD MC-GGFG-EXATECAN
40544 A II 2024/09/19 BEIJING HOPE PHARMACEUTICAL CO LTD RELUGOLIX
40060 A II 2024/09/19 DIVIS LABORATORIES LTD RIVAROXABAN USP
40342 A II 2024/09/18 YANGZHOU AURISCO PHARMACEUTICAL CO LTD BRIVARACETAM
40388 A II 2024/09/18 APITORIA PHARMA PRIVATE LTD GLYCEROL PHENYLBUTYRATE
40411 A II 2024/09/18 HETERO LABS LTD BEROTRALSTAT DIHYDROCHLORIDE
40314 A IV 2024/09/18 AVT (SHANGHAI) PHARMACEUTICAL TECH CO LTD L-HISTIDINE
40433 A II 2024/09/17 JIANGXI SYNERGY PHARMACEUTICAL CO LTD AZILSARTAN
40276 A II 2024/09/17 3D IMAGING DRUG DESIGN AND DEVELOPMENT LLC I-124 HJAA-F11
40379 A II 2024/09/16 HUAYI ISOTOPES CO METHYLENEDIPHOSPHONIC ACID RADIOPHARMACEUTICAL PREPARATIONS
40401 A IV 2024/09/16 LUX FLAVOURS CAPSIL ORANGE FLAVOR
40281 A II 2024/09/16 ABX ADVANCED BIOCHEMICAL COMPOUNDS BIOMEDIZINISCHE FORSCHUNGSREAGENZIEN GMBH [18O] WATER
40302 A II 2024/09/16 BESTCHROM (ZHEJIANG) BIOSCIENCES LTD Q BESTAROSE FF
39943 A II 2024/09/15 HUBEI HONCH PHARMACEUTICAL CO LTD VINCRISTINE SULFATE
40466 A V 2024/09/13 WUXI BIOLOGICS BIOSAFETY TESTING (SUZHOU) CO LTD CONTRACT LABORATORY TEST METHOD
40473 A II 2024/09/13 TANGYI HEALTHINA (SHENZHEN) MEDICAL BIOTECHNOLOGY CO CRYOPRESERVATION SOLUTION
40479 A II 2024/09/13 PORTON PHARMA SOLUTIONS LTD SODIUM (S)-4-OXO-4,6,7,8-TETRAHYDROPYRROLO[1,2-A]PYRIMIDINE-6-CARBOXYLATE
40191 A II 2024/09/13 GLAND CHEMICALS PRIVATE LTD ERTAPENEM SODIUM
40382 A II 2024/09/12 SYNAFFIX BV GLYCOSYLTRANSFERASE (GT)

数据库说明:

当前数据更新日期:2025年10月13日(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2025 DrugFuture->U.S. FDA Drug Master Files